Adrenal cortical carcinoma with tumor thrombus extension into the right atrium: A case report

Wang,Yimin; Zhou,Feng; Pan,Hao; Jin,Baiye

doi:10.3892/ol.2016.4502

Adrenal cortical carcinoma with tumor thrombus extension into the right atrium: A case report

Authors:
- Yimin Wang
- Feng Zhou
- Hao Pan
- Baiye Jin
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China
Published online on: April 26, 2016 https://doi.org/10.3892/ol.2016.4502
Pages: 3987-3991
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adrenal cortical carcinoma (ACC) is a rare aggressive malignant tumor associated with a poor prognosis. Patients with ACC usually present with abnormal hormone secretion, tumor growth or encroachment on the surrounding viscera. An early diagnosis of ACC is considered challenging. The present study reports a case of ACC with tumor thrombus extension into the inferior vena cava and right atrium. A 33‑year‑old male patient exhibited symptoms of gynecomastia and abdominal distention, which were due to the abnormal hormone secretion levels and to the presence of a large mass in the right adrenal gland. An en bloc resection of the tumor was the selected treatment option. Extirpation of the tumor thrombus was performed by means of extracorporeal circulation. No signs of metastasis or recurrence were identified at the 1‑month follow‑up.

View Figures

View References

1.	Aubert S, Wacrenier A, Leroy X, Devos P, Carnaille B, Proye C, Wemeau JL, Lecomte-Houcke M and Leteurtre E: Weiss system revisited: A clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol. 26:1612–1619. 2002. View Article : Google Scholar : PubMed/NCBI
2.	Roman S: Adrenocortical carcinoma. Curr Opin Oncol. 18:36–42. 2006. View Article : Google Scholar : PubMed/NCBI
3.	Fassnacht M and Allolio B: Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 23:273–289. 2009. View Article : Google Scholar : PubMed/NCBI
4.	Ng L and Libertino JM: Adrenocortical carcinoma: Diagnosis, evaluation and treatment. J Urol. 169:5–11. 2003. View Article : Google Scholar : PubMed/NCBI
5.	Ekici S and Ciancio G: Surgical management of large adrenal masses with or without thrombus extending into the inferior vena cava. J Urol. 172:2340–2343. 2004. View Article : Google Scholar : PubMed/NCBI
6.	Hoffman DL and Mattox VR: Treatment of adrenal cortical carcinoma with o,p'-DDD. Med Clin North Am. 56:999–1012. 1972. View Article : Google Scholar : PubMed/NCBI
7.	Luton JP, Cerdas S, Billaud L, Thomas G, Guilhaume B, Bertagna X, Laudat MH, Louvel A, Chapuis Y and Blondeau P: Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 322:1195–1201. 1990. View Article : Google Scholar : PubMed/NCBI
8.	Nardi P, Pellegrino A, Pugliese M, Bovio E, Chiariello L and Ruvolo G: Cardiac surgery with extracorporeal circulation and concomitant malignancy: Early and long-term results. J Cardiovasc Med (Hagerstown). 17:152–159. 2016. View Article : Google Scholar : PubMed/NCBI
9.	Bertherat J, Coste J and Bertagna X: Adjuvant mitotane in adrenocortical carcinoma. N Engl J Med. 357:1256–1257. 2007. View Article : Google Scholar : PubMed/NCBI
10.	Kerkhofs TM, Verhoeven RH, Van der Zwan JM, Dieleman J, Kerstens MN, Links TP, Van de Poll-Franse LV and Haak HR: Adrenocortical carcinoma: A population-based study on incidence and survival in the Netherlands since 1993. Eur J Cancer. 49:2579–2586. 2013. View Article : Google Scholar : PubMed/NCBI
11.	Kebebew E, Reiff E, Duh QY, Clark OH and McMillan A: Extent of disease at presentation and outcome for adrenocortical carcinoma: Have we made progress? World J Surg. 30:872–878. 2006. View Article : Google Scholar : PubMed/NCBI
12.	Puvaneswary M and Thong K: Primary hyperaldosteronism: Due to adrenal cortical carcinoma. Australas Radiol. 37:88–89. 1993. View Article : Google Scholar : PubMed/NCBI
13.	Coonrod DV and Rizkallah TH: Virilizing adrenal carcinoma in a woman of reproductive age: A case presentation and literature review. Am J Obstet Gynecol. 172:1912–1915. 1995. View Article : Google Scholar : PubMed/NCBI
14.	Lanigan D, Choa RG and Evans J: A feminizing adrenocortical carcinoma presenting with gynaecomastia. Postgrad Med J. 69:481–483. 1993. View Article : Google Scholar : PubMed/NCBI
15.	Chiche L, Dousset B, Kieffer E and Chapuis Y: Adrenocortical carcinoma extending into the inferior vena cava: Presentation of a 15-patient series and review of the literature. Surgery. 139:15–27. 2006. View Article : Google Scholar : PubMed/NCBI
16.	Tritos NA, Cushing GW, Heatley G and Libertino JA: Clinical features and prognostic factors associated with adrenocortical carcinoma: Lahey Clinic Medical Center experience. Am Surg. 66:73–79. 2000.PubMed/NCBI
17.	Bodie B, Novick AC, Pontes JE, Straffon RA, Montie JE, Babiak T, Sheeler L and Schumacher P: The Cleveland Clinic experience with adrenal cortical carcinoma. J Urol. 141:257–260. 1989.PubMed/NCBI
18.	Hedican SP and Marshall FF: Adrenocortical carcinoma with intracaval extension. J Urol. 158:2056–2061. 1997. View Article : Google Scholar : PubMed/NCBI
19.	Lebastchi AH, Kunstman JW and Carling T: Adrenocortical carcinoma: Current therapeutic state-of-the-art. J Oncol. 2012:2347262012. View Article : Google Scholar : PubMed/NCBI
20.	Allolio B, Hahner S, Weismann D and Fassnacht M: Management of adrenocortical carcinoma. Clin Endocrinol (Oxf). 60:273–287. 2004. View Article : Google Scholar : PubMed/NCBI
21.	Dackiw AP, Lee JE, Gagel RF and Evans DB: Adrenal cortical carcinoma. World J Surg. 25:914–926. 2001. View Article : Google Scholar : PubMed/NCBI
22.	Ochi T, Tanji N, Shimamoto K, Ikeda T, Toshino A and Yokoyama M: Application of cardiopulmonary bypass for resection of renal cell carcinoma and adrenocortical carcinoma extending into the right atrium. Int J Urol. 13:202–205. 2006. View Article : Google Scholar : PubMed/NCBI
23.	Haak HR, Hermans J, van de Velde CJ, Lentjes EG, Goslings BM, Fleuren GJ and Krans HM: Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients. Br J Cancer. 69:947–951. 1994. View Article : Google Scholar : PubMed/NCBI
24.	Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, et al: Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med. 356:2372–2380. 2007. View Article : Google Scholar : PubMed/NCBI
25.	Berruti A, Fassnacht M, Baudin E, Hammer G, Haak H, Leboulleux S, Skogseid B, Allolio B and Terzolo M: Adjuvant therapy in patients with adrenocortical carcinoma: A position of an international panel. J Clin Oncol. 28:e401–e402. 2010. View Article : Google Scholar : PubMed/NCBI